Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial - Concepedia

Concepedia

Publication | Open Access

Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial

DOI Full Paper Access

126

Citations

27

References

2022

Year

Scott S. Tykodi, Lucio Gordan, Robert Alter, Edward Arrowsmith, Michael R. Harrison, Ivor Percent, Rakesh Singal, Peter J. Van Veldhuizen, Daniel J. George, Thomas E. Hutson,

Journal for ImmunoTherapy of Cancer

Abstract

NCT02982954.

References

	Year	Citations

Page 1